{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T05:38:41Z","timestamp":1777181921742,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.clon.2015.09.006","type":"journal-article","created":{"date-parts":[[2015,10,24]],"date-time":"2015-10-24T17:32:42Z","timestamp":1445707962000},"page":"165-170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Prostate Dose-painting Radiotherapy and Radiobiological Guided Optimisation Enhances the Therapeutic Ratio"],"prefix":"10.1016","volume":"28","author":[{"given":"J.","family":"Uzan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.E.","family":"Nahum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Syndikus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clon.2015.09.006_bib1","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1470-2045(07)70143-2","article-title":"Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial","volume":"8","author":"Dearnaley","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clon.2015.09.006_bib2","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.ijrobp.2009.08.040","article-title":"Predicting post-external beam radiation therapy PSA relapse of prostate cancer using pretreatment MRI","volume":"78","author":"Fuchsj\u00e4ger","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2015.09.006_bib3","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.clon.2013.05.002","article-title":"Focal therapy for prostate cancer: rationale and treatment opportunities","volume":"25","author":"Kasivisvanathan","year":"2013","journal-title":"Clin Oncol"},{"key":"10.1016\/j.clon.2015.09.006_bib4","doi-asserted-by":"crossref","first-page":"e441","DOI":"10.1016\/j.ijrobp.2011.05.035","article-title":"Pathological predictors for site of local recurrence after radiotherapy for prostate cancer","volume":"82","author":"Chopra","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2015.09.006_bib5","doi-asserted-by":"crossref","first-page":"e787","DOI":"10.1016\/j.ijrobp.2011.11.030","article-title":"Does local recurrence of prostate cancer after radiation therapy occur at the site of primary tumor? Results of a longitudinal MRI and MRSI study","volume":"82","author":"Arrayeh","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2015.09.006_bib6","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1148\/radiol.13120641","article-title":"Multiparametric MR imaging for detection of clinically significant prostate cancer: a validation cohort study with transperineal template prostate mapping as the reference standard","volume":"268","author":"Arumainayagam","year":"2013","journal-title":"Radiology"},{"key":"10.1016\/j.clon.2015.09.006_bib7","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.ejmp.2012.10.002","article-title":"Biological optimization of simultaneous boost on intra-prostatic lesions (DILs): sensitivity to TCP parameters","volume":"29","author":"Azzeroni","year":"2013","journal-title":"Phys Med"},{"key":"10.1016\/j.clon.2015.09.006_bib8","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.3109\/0284186X.2010.486796","article-title":"Severe hypofractionation: the usefulness of non-homogeneous tumour dose delivery in counteracting tumour hypoxia","volume":"49","author":"Ruggieri","year":"2010","journal-title":"Acta Oncol"},{"key":"10.1016\/j.clon.2015.09.006_bib9","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1748-717X-7-14","article-title":"Dose-escalation using intensity-modulated radiotherapy for prostate cancer \u2013 evaluation of quality of life with and without (18)F-choline PET-CT detected simultaneous integrated boost","volume":"7","author":"Pinkawa","year":"2012","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.clon.2015.09.006_bib10","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.ijrobp.2010.06.050","article-title":"Parameters favorable to intraprostatic radiation dose escalation in men with localized prostate cancer","volume":"80","author":"Housri","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2015.09.006_bib11","doi-asserted-by":"crossref","first-page":"e423","DOI":"10.1016\/j.ijrobp.2011.01.048","article-title":"Image-guided radiotherapy for prostate cancer: a prospective trial of concomitant boost using indium-111-capromab pendetide (ProstaScint) imaging","volume":"81","author":"Wong","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2015.09.006_bib12","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.ijrobp.2010.04.025","article-title":"Volumetric arc therapy and intensity-modulated radiotherapy for primary prostate radiotherapy with simultaneous integrated boost to intraprostatic lesion with 6 and 18 MV: a planning comparison study","volume":"79","author":"Ost","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2015.09.006_bib13","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.radonc.2013.04.027","article-title":"Boosting imaging defined dominant prostatic tumors: a systematic review","volume":"107","author":"Bauman","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2015.09.006_bib14","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1118\/1.3685586","article-title":"Experimental assessments of intrafractional prostate motion on sequential and simultaneous boost to a dominant intraprostatic lesion","volume":"39","author":"Abdellatif","year":"2012","journal-title":"Med Phys"},{"key":"10.1016\/j.clon.2015.09.006_bib15","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1118\/1.3116775","article-title":"Improved critical structure sparing with biologically based IMRT optimization","volume":"36","author":"Qi","year":"2009","journal-title":"Med Phys"},{"key":"10.1016\/j.clon.2015.09.006_bib16","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1007\/s00330-011-2377-y","article-title":"ESUR prostate MR guidelines 2012","volume":"22","author":"Barentsz","year":"2012","journal-title":"Eur Radiol"},{"key":"10.1016\/j.clon.2015.09.006_bib17","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.radonc.2014.02.009","article-title":"Impact of planning target volume margins and rectal distention on biochemical failure in image-guided radiotherapy of prostate cancer","volume":"111","author":"Engels","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2015.09.006_bib18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1748-717X-5-23","article-title":"Choline PET based dose-painting in prostate cancer \u2013 modelling of dose effects","volume":"5","author":"Niyazi","year":"2010","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.clon.2015.09.006_bib19","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1470-2045(11)70293-5","article-title":"Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled trial","volume":"13","author":"Dearnaley","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clon.2015.09.006_bib20","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.ijrobp.2012.07.006","article-title":"Direct 2-arm comparison shows benefit of high-dose-rate brachytherapy boost vs. external beam radiation therapy alone for prostate cancer","volume":"85","author":"Khor","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2015.09.006_bib21","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.radonc.2012.03.002","article-title":"The dose-response of the anal sphincter region \u2013an analysis of data from the MRC RT01 trial","volume":"103","author":"Buettner","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2015.09.006_bib22","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.radonc.2009.08.004","article-title":"Dose-volume effects for normal tissues in external radiotherapy: pelvis","volume":"93","author":"Fiorino","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2015.09.006_bib23","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ijrobp.2013.03.020","article-title":"A\u00a0novel method for\u00a0predicting late genitourinary toxicity after prostate radiation therapy and the need for age-based risk-adapted dose constraints","volume":"86","author":"Ahmed","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2015.09.006_bib24","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1259\/bjr\/20476567","article-title":"Radiobiologically guided optimisation of the prescription dose and fractionation scheme in radiotherapy using BioSuite","volume":"85","author":"Uzan","year":"2012","journal-title":"Br J Radiol"},{"key":"10.1016\/j.clon.2015.09.006_bib25","doi-asserted-by":"crossref","first-page":"329214","DOI":"10.1155\/2012\/329214","article-title":"(Radio)biological optimization of external-beam radiotherapy","volume":"2012","author":"Nahum","year":"2012","journal-title":"Comput Math Meth Med"},{"key":"10.1016\/j.clon.2015.09.006_bib26","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijrobp.2006.03.034","article-title":"Rectal bleeding, faecal incontinence, and high stool frequency after conformal radiotherapy for prostate cancer: normal tissue complication probability modelling","volume":"66","author":"Peeters","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2015.09.006_bib27","doi-asserted-by":"crossref","first-page":"S286","DOI":"10.1016\/j.ijrobp.2008.06.1026","article-title":"Pre-treatment nomograms predicting severe rectal toxicity after prostate cancer 3D-CRT","volume":"72","author":"Rancati","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"22","key":"10.1016\/j.clon.2015.09.006_bib28","doi-asserted-by":"crossref","first-page":"6345","DOI":"10.1088\/0031-9155\/53\/22\/006","article-title":"Convex reformulation of biologically-based multi-criteria intensity-modulated radiation therapy optimization including fractionation effects","volume":"53","author":"Hoffmann","year":"2008","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.clon.2015.09.006_bib29","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3109\/0284186X.2010.530688","article-title":"Feasibility of safe ultra-high (EQD(2)>100 Gy) dose escalation on dominant intra-prostatic lesions (DILs) by helical tomotheraphy","volume":"50","author":"Maggio","year":"2011","journal-title":"Acta Oncol"},{"key":"10.1016\/j.clon.2015.09.006_bib30","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/1745-6215-12-255","article-title":"Single blind randomized phase III trial to investigate the benefit of a focal lesion ablative microboost in prostate cancer (FLAME-trial): study protocol for a randomized controlled trial","volume":"12","author":"Lips","year":"2011","journal-title":"Trials"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655515003581?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655515003581?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:41:20Z","timestamp":1760542880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655515003581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S0936655515003581"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2015.09.006","relation":{},"ISSN":["0936-6555"],"issn-type":[{"value":"0936-6555","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prostate Dose-painting Radiotherapy and Radiobiological Guided Optimisation Enhances the Therapeutic Ratio","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2015.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}